Larvol Delta - Results-of-ALLEVIATE1-and-ALLEVIATE2-Phase-3-trials-of-cebranopadol-a-firstinclass-dual-NOPMOP-receptor-agonist-for-the-treatment-of-acute-pain-after-abdominoplasty-and-bunionectomy

cebranopadol (TRN-228) - Tris Pharma

https://painconnect.org/wp-content/uploads/2026/02/AAPM-2026-Working-Agenda_02.27.26.pdf

Todd Bertoch, MD

Feb 12, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next